Identification of a central role for complement in osteoarthritis

Area of Science:

• Immunology
• Rheumatology
• Molecular Biology

Background:

• Osteoarthritis (OA) involves articular cartilage breakdown in synovial joints.
• The role of low-grade inflammation in OA pathogenesis remains unclear.
• The complement system is a key part of the immune system.

Purpose of the Study:

• To investigate the role of the inflammatory complement system in osteoarthritis pathogenesis.
• To determine if complement activation is elevated in human osteoarthritic joints.
• To assess the impact of complement inhibition on OA development in mouse models.

Main Methods:

• Proteomic and transcriptomic analyses of synovial fluids and membranes from OA patients.
• Studies using mice genetically deficient in complement components (C5, C6) or regulatory proteins (CD59a).
• Pharmacological inhibition of complement in wild-type mice.
• Analysis of chondrocyte gene expression and molecule production in vitro and in vivo.

Main Results:

• Complement expression and activation are abnormally high in human osteoarthritic joints.
• Complement component 5 (C5) and the membrane attack complex (MAC) are crucial for arthritis development in mouse models.
• Pharmacological complement inhibition reduced OA development in wild-type mice.
• MAC induced inflammatory and degradative molecules in chondrocytes, colocalizing with MMP13 and ERK in human OA cartilage.

Conclusions:

• Dysregulation of the complement system, particularly the MAC-mediated pathway, plays a critical role in osteoarthritis pathogenesis.
• Targeting the complement system may offer a novel therapeutic strategy for osteoarthritis.
• Findings challenge the traditional 'wear and tear' view of OA by highlighting inflammatory mechanisms.